49-Year-old woman presents with foot paresthesia - PowerPoint PPT Presentation

Loading...

PPT – 49-Year-old woman presents with foot paresthesia PowerPoint presentation | free to view - id: 4f521-YjZjZ



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

49-Year-old woman presents with foot paresthesia

Description:

49-Year-old woman presents with foot paresthesia. 49-Year-old woman: Physical exam ... 49-Year-old woman: Management decision. 49-Year-old woman: 3-Month follow-up ... – PowerPoint PPT presentation

Number of Views:121
Avg rating:3.0/5.0
Slides: 29
Provided by: dav5217
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: 49-Year-old woman presents with foot paresthesia


1
(No Transcript)
2
49-Year-old woman presents with foot paresthesia
3
49-Year-old woman Physical exam
4
49-Year-old woman Laboratory results
5
49-Year-old woman Diagnosis
American Diabetes Association (ADA).
www.diabetes.org
England JD et al. Neurology.
200972177-84.
National
Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK). www.niddk.nih.gov
6
Diabetic neuropathy and gender The EURODIAB
study
Tesfaye S et al. N Engl J Med. 2005352341-50.
European Diabetes Prospective Complications Study
7
Diabetic neuropathy
Maser RE et al. J Clin Endocrinol Metab.
2005905896-903. Schönauer M et
al. Diabetes Vasc Dis Res. 20085336-44.
Vinik AI et al. Diabetologia.
200043957-73.
8
Diabetic neuropathy
Centers for Disease Control Prevention (CDC).
www.cdc.gov/diabetes
9
Tesfaye S et al. N Engl J Med. 2005352341-50.
10
Pathogenesis of diabetic neuropathy
Schönauer M et al. Diabetes Vasc Dis Res.
20085336-44. Vincent AM et al.
Endocr Rev. 200425612-28.
11
Cumulative incidence of neuropathy in type 1 DM
is related to
12
EURODIAB Glycemia is not the only risk factor
for distal symmetric neuropathy in type 1 diabetes
13
Risk factors associated with the development of
peripheral sensory neuropathy in T2DM at 5 years
14
DCCT Effect of intensive vs conventional
glycemic control on neuropathy in type 1 diabetes
15
Effect of long-term intensive insulin vs
conventional control on peripheral neuropathy in
T2DM FBG A1C
16
Effect of long-term intensive insulin vs
conventional control on peripheral neuropathy in
T2DM (cont)
17
Diabetic neuropathy in long-standing T2DM may be
irreversible despite improvements in glycemic
control
18
Diabetic neuropathy in long-standing T2DM may be
irreversible despite improvements in Total-C and
TG
19
Systolic BP significantly increased in neuropathy
group despite treatment
20
Prevalence of asymptomatic CAD in diabetes
21
The female diabetic and CAD
22
Gender-specific differences in CAD risk factors
23
Gender-specific differences in CAD interventions
24
LV systolic function abnormalities in diabetic
patients with neuropathy Effects of ARI
treatment
25
Effect of long-term intensive vs conventional
glycemic control on autonomic neuropathy in T2DM
26
49-Year-old woman Management decision
27
49-Year-old woman 3-Month follow-up
28
49-Year-old woman Clinical pearls
About PowerShow.com